Skip to content
  • Tuesday, 27 October 2026
  • 9:45 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Houston Methodist Researchers Identify TDP43 Protein as a Primary Regulator of DNA Mismatch Repair Linking Neurodegeneration and Cancer
Neuroscience & Brain Research

Houston Methodist Researchers Identify TDP43 Protein as a Primary Regulator of DNA Mismatch Repair Linking Neurodegeneration and Cancer

Rifan Muazin Apr 5, 2026 0

In a landmark study that bridges the traditionally separate fields of neurology and oncology, researchers at the Houston Methodist Research…

Read More
Neuroscience & Brain Research

Houston Methodist Researchers Uncover Dual Role of TDP43 Protein in DNA Repair and Disease Progression

Rifan Muazin Mar 27, 2026 0

The biological understanding of neurodegenerative diseases and oncological progression has been fundamentally shifted following a landmark study by investigators at…

Read More
Neuroscience & Brain Research

Houston Methodist Researchers Identify TDP43 Protein as a Key Regulator of DNA Mismatch Repair Linking Neurodegeneration and Cancer

Rifan Muazin Mar 19, 2026 0

In a landmark study that bridges two historically distinct fields of medicine, researchers at the Houston Methodist Research Institute have…

Read More
Regeneron Pharmaceuticals and Telix Pharmaceuticals Forge Strategic Alliance to Advance Precision Oncology Through Radiopharmaceutical InnovationPrecision Calculation Resolves Decades-Long Muon Mystery and Reaffirms the Standard Model of PhysicsBiopharma Leaders Urge Dr. Richard Pazdur to Lead FDA Amidst Crisis of ConfidenceFDA Approves Four Groundbreaking Cancer Drugs in May, Offering New Hope for Hematological and Solid Tumors
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ